Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Cumulus Neuroscience Announces £6 million Funding Round
Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led […]
NHS Digital Appoints Simon Bolton as Interim CEO
NHS Digital has announced today that Simon Bolton has been appointed as its interim CEO. […]
MD Ally Announces $3.5M Seed Round to Connect 9-1-1 and First Responders to Telehealth, Mental Health and Social Services
MD Ally, a 911-powered telehealth company, today announced a $3.5M seed round to expand the […]
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical endpoint data solutions, today announced the close of its […]
Caresyntax Raises $100 Million
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and […]
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK
Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]
Novo Holdings Participates in US$ 80 Million Series C Investment in Indonesia's Largest Health-tech Platform Halodoc
Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, […]
Seed Health Closes $40 Million in Series A Financing
Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced […]
Saudi Arabia Pharmaceutical Drugs Market to Surpass US$ 16,663.1 Million by 2027, Says Coherent Market Insights (CMI)
According to Coherent Market Insights, the Saudi Arabia pharmaceutical drugs market is estimated to be […]
OS Therapies Completes $6 Million Series A Funding Round
OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more